Cannara to Announce Fiscal Q3 2026 Financial Results on July 15, 2026
MONTREAL, July 08, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (https://www.globenewswire.com/Tracker?data=2whZmrnHqSCbvBE0C6LpbqwcJ5xZlSvsYEfdZsmI9_dAJNobCNcBwqndHoXSoUegO6kRNmkn40935E_G2XCkoFo7tSJmdkjcu2mzNwctWV4=) (“Cannara”, the “Company”, “us” or “we”) (TSX: LOVE (https://www.globenewswire.com/Tracker?data=JWdVWPkbrtcsmYvJsUqNuQeER9MA_eapPODxQ8HsYTCiLE6cCsZ47x1YjUIF2vxpbzXZ-_iogr5H1XyC2mqaFL7Cn9VUUZYEOhXfQc6UB54=)) (OTCQX: LOVFF (https://www.globenewswire.com/Tracker?data=mEDpQP-2BmQ7xHS3
Globe Newswire ·